LOOMIS SAYLES & CO L P – BioMarin Pharmaceutical Inc. Transaction History
LOOMIS SAYLES & CO L P portfolio value:
$30.22M
portfolio value
LOOMIS SAYLES & CO L P quarter portfolio value change:
+2.29%
quarter
BioMarin Pharmaceutical Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -6.79% | -25.94K shares | -1.47M | $84.77 | 356.48K |
| Q2 2022 | share | Decrease | -3.22% | -12.73K shares | 1.22M | $82.87 | 382.43K |
| Q1 2022 | share | Decrease | -12.75% | -57.74K shares | -9.54M | $77.1 | 395.17K |
| Q4 2021 | share | Decrease | -2.13% | -9.84K shares | 4.24M | $89.08 | 452.91K |
| Q3 2021 | share | Increase | +0.58% | 2.68K shares | -2.62M | $77.29 | 462.75K |
| Q2 2021 | share | Decrease | -10.82% | -55.82K shares | -566K | $83.44 | 460.07K |
| Q1 2021 | share | Decrease | -0.68% | -3.54K shares | -6.59M | $75.51 | 515.89K |
| Q4 2020 | share | Decrease | -10.73% | -62.44K shares | 1.27M | $87.69 | 519.44K |
| Q3 2020 | share | Decrease | -5.09% | -31.17K shares | -31.34M | $76.08 | 581.88K |
| Q2 2020 | share | Decrease | -4.81% | -31.00K shares | 21.19M | $123.34 | 613.06K |
| Q1 2020 | share | Decrease | -7.65% | -53.36K shares | -4.54M | $84.5 | 644.07K |
| Q4 2019 | share | Decrease | -15.89% | -131.71K shares | 3.08M | $84.55 | 697.43K |
| Q3 2019 | share | Decrease | -2.81% | -23.93K shares | -17.18M | $67.4 | 829.14K |
| Q2 2019 | share | Decrease | -0.52% | -4.48K shares | -3.11M | $85.65 | 853.07K |
| Q1 2019 | share | Increase | +1.22% | 10.35K shares | 4.03M | $88.83 | 857.55K |
| Q4 2018 | share | Decrease | -7.90% | -72.68K shares | -17.06M | $85.15 | 847.20K |
| Q3 2018 | share | Decrease | -2.27% | -21.40K shares | 532K | $96.97 | 919.88K |
| Q2 2018 | share | Increase | +8.12% | 70.65K shares | 18.08M | $94.2 | 941.29K |
| Q1 2018 | share | Increase | 0.00% | 870.63K shares | 70.58M | $81.07 | 870.63K |